PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Compound Kushen Injection (containing Smilax glabra Roxb.) significantly improved complete remission and partial response rates compared to patients without the injection [PMID:38579051]
Topical application of extract and use in herb pairs (with Cimicifugae Rhizoma) improved psoriatic lesions in mouse models [PMID:35963195, PMID:40876428]
Demonstrated uric acid lowering effects by regulating renal urate transporters (upregulating OAT1/ABCG2, downregulating URAT1) and remodeling intestinal microbiota in mice [PMID:40624868, PMID:37132060]
Alleviated AKI in mice by activating the Nrf2/HO-1 signaling pathway [PMID:40043544]
Engeletin and polysaccharides from S. glabra mitigated intestinal mucosal damage and restored barrier integrity in mice [PMID:40427406, PMID:37836386]
Evidence summary
PubMed sources
- 1.PMID: 40043544 (2025) — Smilax glabra roxb. alleviates cisplatin-induced acute kidney injury in mice by activating the Nrf2/HO-1 Signalling Pathway. · Phytomedicine : international journal of phytotherapy and phytopharmacology
- 2.PMID: 35963195 (2022) — Combining network pharmacology, RNA-seq, and metabolomics strategies to reveal the mechanism of Cimicifugae Rhizoma - Smilax glabra Roxb herb pair for the treatment of psoriasis. · Phytomedicine : international journal of phytotherapy and phytopharmacology
- 3.PMID: 38820662 (2024) — Astilbin inhibited neutrophil extracellular traps in gouty arthritis through suppression of purinergic P2Y6 receptor. · Phytomedicine : international journal of phytotherapy and phytopharmacology
- 4.PMID: 41477354 (2025) — Butyrylated Smilax glabra starch relieves atopic dermatitis through gut-skin axis modulation via colon-targeted delivery. · Acta pharmaceutica Sinica. B
- 5.